Spontaneous subarachnoid hemorrhage (SAH), commonly caused by the rupture of an
intracerebral aneurysm (85% of all cases of SAH), remains a life-threatening condition with …

Aneurysmal subarachnoid haemorrhage (aSAH) is a rare yet profoundly debilitating
condition associated with high global case fatality and morbidity rates. The key determinants …

Purpose Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral
ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups …

Milrinone (MLN) is a second-generation bipyridine phosphodiesterase (PDE) inhibitor
developed by modifying amrinone chemically. It is a PDE-III antagonist that promotes …

Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (aSAH) is a
singular pathological entity necessitating early diagnostic approaches and both prophylactic …

Introduction Tissue hypoxia and insufficient energy delivery is one of the mechanisms
behind the occurrence of several complications in acute brain injured patients. Several …

We read with great interest the practice guidance article by Deem et al.[1] regarding the
hemodynamic management in the prevention and treatment of delayed cerebral ischemia …

Background Cerebral vasospasm (CVS) continues to account for high morbidity and
mortality in patients surviving the initial aneurysmal subarachnoid hemorrhage (SAH) …

Background Children with congenital heart disease (CHD) are easily complicated by severe
pneumonia and heart failure. We aimed to conduct a meta-analysis to evaluate the effects …

Knowledge on the spectral properties of the tautomers of milrinone (MLR) in solvents and
solid-state, as well as under light conditions is of critical importance from both theoretical …